Could a new heartburn drug interfere with Life-Saving blood thinners?
NCT ID NCT07471867
First seen Apr 07, 2026 · Last updated May 01, 2026 · Updated 4 times
Summary
This study looks at whether a new acid reflux drug, ZaStaprazan, changes how well the blood thinner clopidogrel works in people with chronic heart disease who have had a stent placed. About 100 adults will be randomly assigned to receive either ZaStaprazan or a standard acid reflux drug. The main goal is to measure blood clotting activity one month after starting the medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yongin Severance Hospital, Yonsei University
RECRUITINGYongin-si, Gyeonggi-do, 16995, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.